ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Senators Call Mammography Debate Confusing, Say Screening “Saves Lives”.

March 8, 2002

NIH News: PubMed Central Is Name Of New NIH PLAN For Electronic Publishing

September 10, 1999

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Jill ElkenberryTo Get ACCC Award

March 17, 1989

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977